These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12769203)

  • 41. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
    Audibert F; Gagnon A; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Second trimester prenatal ultrasound for the detection of pregnancies at increased risk of Down syndrome.
    Smith-Bindman R; Chu P; Goldberg JD
    Prenat Diagn; 2007 Jun; 27(6):535-44. PubMed ID: 17367102
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic sonography after first-trimester Down syndrome screening.
    Krantz DA; Hallahan TW; Macri VJ; Macri JN
    Ultrasound Obstet Gynecol; 2007 Jun; 29(6):666-70. PubMed ID: 17492748
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnosis and management of fetal nuchal translucency.
    Jackson M; Rose NC
    Semin Roentgenol; 1998 Oct; 33(4):333-8. PubMed ID: 9800243
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of first trimester screening and early fetal anomaly scan on invasive testing rates in women with advanced maternal age.
    Hagen A; Entezami M; Gasiorek-Wiens A; Albig M; Becker R; Knoll U; Stumm M; Wegner RD
    Ultraschall Med; 2011 Jun; 32(3):302-6. PubMed ID: 20972947
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost-effectiveness model for first-trimester versus second-trimester ultrasound screening for Down syndrome.
    Kott B; Dubinsky TJ
    J Am Coll Radiol; 2004 Jun; 1(6):415-21. PubMed ID: 17411619
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost-benefit analysis of targeted ultrasonography for prenatal detection of spina bifida in patients with an elevated concentration of second-trimester maternal serum alpha-fetoprotein.
    Vintzileos AM; Ananth CV; Fisher AJ; Smulian JC; Day-Salvatore D; Beazoglou T; Knuppel RA
    Am J Obstet Gynecol; 1999 May; 180(5):1227-33. PubMed ID: 10329882
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of ultrasonographic markers for trisomy 21 in women with positive serum biochemistry.
    Verdin SM; Economides DL
    Br J Obstet Gynaecol; 1998 Jan; 105(1):63-7. PubMed ID: 9442164
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early genetic sonogram for Down syndrome detection.
    Bahado-Singh RO; Mendilcioglu I; Rowther M; Choi SJ; Oz U; Yousefi NF; Mahoney MJ
    Am J Obstet Gynecol; 2002 Nov; 187(5):1235-8. PubMed ID: 12439511
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Choroid plexus cysts and risk of trisomy 18. Modifications regarding maternal age and markers].
    Hurt K; Sottner O; Záhumenský J; Halaska M; Krcmár M; Driák D; Zmrhalová B; Rakovicová I
    Ceska Gynekol; 2007 Jan; 72(1):49-52. PubMed ID: 17357350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Down syndrome: prenatal risk assessment and diagnosis.
    Newberger DS
    Am Fam Physician; 2000 Aug; 62(4):825-32, 837-8. PubMed ID: 10969860
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Second trimester ultrasound screening for chromosomal abnormalities.
    Shipp TD; Benacerraf BR
    Prenat Diagn; 2002 Apr; 22(4):296-307. PubMed ID: 11981910
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
    Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Second-trimester ultrasound to detect fetuses with Down syndrome: a meta-analysis.
    Smith-Bindman R; Hosmer W; Feldstein VA; Deeks JJ; Goldberg JD
    JAMA; 2001 Feb; 285(8):1044-55. PubMed ID: 11209176
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adjusting the risk for trisomy 21 by a simple ultrasound method using fetal long-bone biometry.
    Vintzileos AM; Egan JF; Smulian JC; Campbell WA; Guzman ER; Rodis JF
    Obstet Gynecol; 1996 Jun; 87(6):953-8. PubMed ID: 8649705
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Advanced maternal age as a sole indication for genetic amniocentesis; risk-benefit analysis based on a large database reflecting the current common practice.
    Bornstein E; Lenchner E; Donnenfeld A; Barnhard Y; Seubert D; Divon MY
    J Perinat Med; 2009; 37(2):99-102. PubMed ID: 18999912
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of genetic sonography for adjusting the risk for fetal Down syndrome.
    Nyberg DA; Souter VL
    Semin Perinatol; 2003 Apr; 27(2):130-44. PubMed ID: 12769199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.